Adults aged 65 and older who took semaglutide 2.4 mg lost an average of 15.4% of their body weight over 68 weeks, according ...

FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell ...

Introduction Mental health is an urgent public health issue with social and economic relevance. Business families play a key ...

Into the Blue, a new program letting creators pitch product ideas and work with Lowe’s teams to develop and potentially ...

FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...

In this multicentre, prospective, observational, diagnostic accuracy study of children with suspected pulmonary embolism in ...

Spread the love“`html Plantar fasciitis is a common foot condition that affects millions of people worldwide. Characterized ...